⌛ Did you miss ProPicks’ 13% gains in May? Subscribe now & catch June’s top AI-picked stocks early.Unlock Stocks

Abacus Life prices $25M public offering of notes

Published 12/02/2024, 14:58
© Reuters.
ABL
-

ORLANDO, Fla. - Abacus Life, Inc. (NASDAQ: ABL; ABLLL), a market maker and asset manager in the life insurance sector, has announced the pricing of its public offering of $25 million in additional 9.875% notes due in 2028. The new issuance, expected to close on February 15, 2024, will be treated as a single series with the existing notes issued last November, bringing the total outstanding notes to $60.65 million.

The underwriters, led by Piper Sandler & Co., A.G.P./Alliance Global Partners (NYSE:GLP), and Ladenburg Thalmann & Co. Inc., have the option to purchase up to an additional $3.75 million in notes to cover any overallotments. The funds raised from this offering are earmarked for refinancing existing debt and general corporate purposes.

Abacus Life, which specializes in longevity and actuarial technology, intends to list the new notes on the Nasdaq Global Market under the symbol "ABLLL," the same as the existing notes. The company, which has been operational since 2004, is known for its role in purchasing life insurance policies and managing them through various strategies.

Abacus Life maintains an A+ rating as a BBB Accredited Business. The company has built a substantial presence in the industry, with over $4.6 billion in face value of policies purchased, and has established a network of institutional partners and financial advisors across 49 states.

The information in this article is based on a press release statement by Abacus Life, Inc.

InvestingPro Insights

As Abacus Life, Inc. (NASDAQ: ABL; ABLLL) gears up for its public offering of additional notes, investors are closely monitoring the company's financial health and market performance. According to InvestingPro data, Abacus Life currently boasts a robust market capitalization of 729.94 million USD, indicative of investor confidence and the company's market presence.

With an impressive revenue growth of 92.2% over the last twelve months as of Q1 2023, Abacus Life's financial trajectory appears strong. This growth is further underscored by a significant gross profit margin of 87.45%, suggesting efficient management and a solid business model. Additionally, the company has demonstrated a substantial return on assets of 13.23%, reflecting its ability to generate earnings from its asset base.

InvestingPro Tips for Abacus Life highlight that the company's liquid assets currently exceed its short-term obligations, providing financial stability and the ability to meet immediate financial needs. Moreover, Abacus Life has experienced a strong return over the last three months, with a 69.25% price total return, which could be a positive signal for investors looking for momentum in the market.

For investors seeking a deeper dive into Abacus Life's financials and market performance, additional InvestingPro Tips are available, including insights into the company's trading multiples and dividend policies. To explore these further, visit InvestingPro and consider using the coupon code PRONEWS24 to get an additional 10% off a yearly or biyearly Pro and Pro+ subscription. With these resources, investors can make more informed decisions backed by real-time data and expert analysis.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Loading next article…
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.